Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa I Backus

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Public Health Reports (Washington, D.C. : 1974)|January 31, 2017
Engagement in the Hepatitis C Care Cascade Among Homeless Veterans, 2015Amanda J Noska, Pamela S Belperio, Timothy P Loomis, et al.
Annals of Internal Medicine|December 16, 2014
Screening for and prevalence of hepatitis B virus infection among high-risk veterans under the care of the U.S. Department of Veterans Affairs: a case reportLisa I Backus, Pamela S Belperio, Timothy P Loomis, et al.
Hepatology (Baltimore, Md.)|April 27, 2016
Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patientsLisa I Backus, Pamela S Belperio, Troy A Shahoumian, et al.
JAMA Internal Medicine|July 10, 2013
Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs careLisa I Backus, Pamela S Belperio, Timothy P Loomis, et al.
Antiviral Therapy|December 10, 2016
Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patientsLisa I Backus, Pamela S Belperio, Troy A Shahoumian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2017
Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States VeteransAmanda J Noska, Pamela S Belperio, Timothy P Loomis, et al.
Journal of Hepatology|September 30, 2018
Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3Pamela S Belperio, Troy A Shahoumian, Timothy P Loomis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2011
A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis CLisa I Backus, Derek B Boothroyd, Barbara R Phillips, et al.
The Annals of Pharmacotherapy|October 23, 2008
Postmarketing use of enfuvirtide in veterans: provider compliance with criteria for use, overall efficacy, and tolerabilityPamela S Belperio, Larry A Mole, James Halloran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2013
Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis CPamela S Belperio, Elizabeth W Hwang, I Chun Thomas, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Public Health Reports (Washington, D.C. : 1974)|January 31, 2017
Engagement in the Hepatitis C Care Cascade Among Homeless Veterans, 2015Amanda J Noska, Pamela S Belperio, Timothy P Loomis, et al.
Annals of Internal Medicine|December 16, 2014
Screening for and prevalence of hepatitis B virus infection among high-risk veterans under the care of the U.S. Department of Veterans Affairs: a case reportLisa I Backus, Pamela S Belperio, Timothy P Loomis, et al.
Hepatology (Baltimore, Md.)|April 27, 2016
Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patientsLisa I Backus, Pamela S Belperio, Troy A Shahoumian, et al.
JAMA Internal Medicine|July 10, 2013
Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs careLisa I Backus, Pamela S Belperio, Timothy P Loomis, et al.
Antiviral Therapy|December 10, 2016
Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patientsLisa I Backus, Pamela S Belperio, Troy A Shahoumian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2017
Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States VeteransAmanda J Noska, Pamela S Belperio, Timothy P Loomis, et al.
Journal of Hepatology|September 30, 2018
Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3Pamela S Belperio, Troy A Shahoumian, Timothy P Loomis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2011
A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis CLisa I Backus, Derek B Boothroyd, Barbara R Phillips, et al.
The Annals of Pharmacotherapy|October 23, 2008
Postmarketing use of enfuvirtide in veterans: provider compliance with criteria for use, overall efficacy, and tolerabilityPamela S Belperio, Larry A Mole, James Halloran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2013
Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis CPamela S Belperio, Elizabeth W Hwang, I Chun Thomas, et al.
Pageof 4